Future Clinical Trials Consulting — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Future Clinical Trials Consulting is a specialized digital health services firm offering high-level clinical development expertise as a service. Founded in 2018 by Dr. Silvija Jarnjak, an MD, PhD with over 20 years of experience including a senior role at GSK, the company acts as an independent medical monitor and strategic consultant. It primarily serves biotech sponsors and CROs, providing senior medical leadership for clinical trials in oncology, immunotherapy, and complex autoimmune diseases. The model emphasizes direct access, continuity, and deep therapeutic expertise to de-risk and accelerate client programs.

OncologyImmunotherapyAutoimmune DiseasesRare Diseases

Technology Platform

None. The company is a pure-play consultancy leveraging the deep clinical expertise and methodology of its founder.

Opportunities

Growing demand from resource-constrained biotech sponsors for flexible, senior medical expertise.

Increasing trial complexity in oncology and immunotherapy creates a need for specialized oversight that large CROs may not provide efficiently.

The trend towards sponsor-CRO hybrid models favors independent experts who can bridge gaps and ensure quality.

Risk Factors

Extreme concentration risk as the business is built entirely around a single individual.

Limited scalability due to the hands-on service model.

Vulnerability to downturns in biotech funding which would directly reduce demand for consulting services.

Competitive Landscape

Competes with the medical monitoring and strategy divisions of large, global CROs (e.g., IQVIA, PPD) on the basis of personal attention and seniority. Also competes with other independent consultants and small boutique firms. Differentiation is achieved through the founder's specific high-profile Big Pharma experience in oncology/immunotherapy and the promise of undiluted, continuous involvement.

More companies in Digital Health & Biotech SaaS →More companies in Switzerland →